Page 1,196«..1020..1,1951,1961,1971,198..1,2101,220..»

I’ve Made BIG Improvements with Parkinson’s Therapy Program – Parkinson’s News Today

Posted: Published on December 6th, 2019

I have been seeing a physical therapist four times a week for the last month. I hadnt injured myself, though I experience aches and pains with Parkinsons disease. My neurologist referred me to a physical therapist who teaches the BIG program. Continue reading

Posted in Parkinson's Treatment | Comments Off on I’ve Made BIG Improvements with Parkinson’s Therapy Program – Parkinson’s News Today

Managing the Cost of Chronic Illness – Parkinson’s News Today

Posted: Published on December 6th, 2019

Chronic illness is expensive. It costs money, time, and peace of mind. Continue reading

Posted in Parkinson's Treatment | Comments Off on Managing the Cost of Chronic Illness – Parkinson’s News Today

Screening Software for Parkinson’s the Focus of New Collaboration – Parkinson’s News Today

Posted: Published on December 6th, 2019

Startup company Jesse Medical and researchers from the Royal Melbourne Institute of Technology (RMIT) have agreed to collaborate on the further development and commercialization of new software to enable early detection and improved monitoring of Parkinsons disease. The screening technology analyzes the results of seven specific drawing and writing tasks, including simple writing and drawing a spiral by joining dots, performed on an interactive tablet, allowing the identification of a patient-specific pattern of motor response. Dexterity information collected through this software provides clinicians with real-time data on fine motor skills that can be used to differentiate between people who do not have Parkinsons and those who may have the disease but still do not show its most common and visible motor symptoms Continue reading

Posted in Parkinson's Treatment | Comments Off on Screening Software for Parkinson’s the Focus of New Collaboration – Parkinson’s News Today

Treating multiple sclerosis with the help of the gut microbiome – FierceBiotech

Posted: Published on December 6th, 2019

The population of bacteria in the gut, known as the microbiome, is of great interest to researchers hoping to harness it to treat a host of diseases. Continue reading

Posted in Parkinson's Treatment | Comments Off on Treating multiple sclerosis with the help of the gut microbiome – FierceBiotech

Parkinson’s disease treatment Market Size Global Projections, Industry Analysis, Size, Share 2019 Report – The Market Stats News

Posted: Published on December 6th, 2019

Parkinsons disease treatment Market research now available at Brand Essence Research encompasses an exhaustive Study of this business space with regards to pivotal industry drivers, market share analysis, and the latest trends characterizing the Parkinsons disease treatment industry landscape. This report also covers details of market size, growth spectrum, and the competitive scenario of Parkinsons disease treatment market in the forecast timeline Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson’s disease treatment Market Size Global Projections, Industry Analysis, Size, Share 2019 Report – The Market Stats News

Parkinson’s Disease Treatment Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 – BoundWatch

Posted: Published on December 6th, 2019

As per the Researchunt market industry research Global Parkinsons Disease Treatment market, global industry analysis, trend, size, share, growth in the database. This industrial research report presents all the valuable information related to the particular product for the Parkinsons Disease Treatment market with highly enlightening format. Global Parkinsons Disease Treatment market gives you and large scale platform with full of golden opportunities to the particular industry, producers, firms, association industries and sellers that are continuously working on their business growth at a world level. Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson’s Disease Treatment Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 – BoundWatch

Intra-Cellular Therapies to Present Data on Lumateperone and ITI-333 at the 58th Annual Meeting of the American College of Neuropsychopharmacology -…

Posted: Published on December 6th, 2019

NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc.(Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that the Company will be presenting at the 58th Annual Meeting of the American College of Neuropsychopharmacology (ACNP) to be held in Hollywood, FL, December 8-11, 2019. Continue reading

Posted in Parkinson's Treatment | Comments Off on Intra-Cellular Therapies to Present Data on Lumateperone and ITI-333 at the 58th Annual Meeting of the American College of Neuropsychopharmacology -…

Multiple Sclerosis Information Page: National Institute of …

Posted: Published on December 6th, 2019

An unpredictable disease of the central nervous system, multiple sclerosis (MS) can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted. Many investigators believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus. Most people experience their first symptoms of MS between the ages of 20 and 40; the initial symptom of MS is often blurred or double vision, red-green color distortion, or even blindness in one eye. Most MS patients experience muscle weakness in their extremities and difficulty with coordination and balance. These symptoms may be severe enough to impair walking or even standing. In the worst cases, MS can produce partial or complete paralysis. Most people with MS also exhibit paresthesias, transitory abnormal sensory feelings such as numbness, prickling, or "pins and needles" sensations. Some may also experience pain. Speech impediments, tremors, and dizziness are other frequent complaints. Occasionally, people with MS have … Continue reading

Posted in MS Treatment | Comments Off on Multiple Sclerosis Information Page: National Institute of …

Detecting Ischemia in Myocardial Bridging With CT Angiography-Derived FFR – The Cardiology Advisor

Posted: Published on December 5th, 2019

For patients with proximal atherosclerotic lesions, machine learning-based computed tomography (CT) angiography-derived fractional flow reserve (FFR) can diagnose functional ischemia with myocardial bridging and atherosclerotic disease, according to a study published in the Canadian Journal of Cardiology. Researchers aimed to assess the diagnostic ability of machine learning-based CT angiography-derived FFR to detect functional ischemia in myocardial bridging, and then compare those results with the results of the invasive FFR procedure in patients with left anterior descending myocardial bridging. Patients underwent a coronary CT angiography, an invasive coronary angiography with FFR measurements, and a clinical exam Continue reading

Posted in Clinical Cardiology | Comments Off on Detecting Ischemia in Myocardial Bridging With CT Angiography-Derived FFR – The Cardiology Advisor

Tackling focal VT may improve catheter ablation in structural heart disease – Cardiac Rhythm News

Posted: Published on December 5th, 2019

Robert Anderson Uncovering and abolishing focal ventricular tachycardia (VT) may further improve outcomes of catheter ablation in the treatment of structural heart disease, a study published in the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology concludes. Robert Anderson (Westmead Hospital, Sydney and Royal Melbourne Hospital, Melbourne, Australia) who lead the study, notes that focal ventricular tachycardias are common in patients with structural heart disease (SHD) and often coexist with re-entrant forms of ventricular tachycardia. Continue reading

Posted in Clinical Cardiology | Comments Off on Tackling focal VT may improve catheter ablation in structural heart disease – Cardiac Rhythm News

Page 1,196«..1020..1,1951,1961,1971,198..1,2101,220..»